Allogene Therapeutics (ALLO) Stock Price & Financial Analysis
Allogene Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Allogene Therapeutics
What is the current stock price for ALLO?
As of the latest trading session, ALLO stock trades at $2.06. The 52-week range is $0.98–$4.46, with a day range of $2.04–$2.15.
What is the P/E ratio for ALLO?
The P/E ratio (Price-to-Earnings) for ALLO is shown in the Key Statistics section. This valuation metric helps compare Allogene Therapeutics, Inc. to industry peers.
Does ALLO pay dividends?
Allogene Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ALLO?
Based on 15 analysts, the consensus for ALLO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ALLO?
Allogene Therapeutics's market capitalization is $495.0M, classifying it as a small-cap company. Allogene Therapeutics operates in the Healthcare sector within the Biotechnology industry.